Vol. 117. Núm. 7. (Julio – Agosto 2026)
Experience With Rituximab in Patients With Pemphigus Vulgaris and Hepatitis B
Rituximab is an anti-CD20 monoclonal antibody used as first-line therapy for moderate-to-severe pemphigus vulgaris. For many years, it was contraindicated in patients with a past medical history of hepatitis B due to the risk of […]
Identification of Novel ATP2C1 Mutations in a Spanish Cohort of Patients With Hailey-Hailey Disease
Hailey-Hailey disease (HHD) is a rare autosomal dominant genodermatosis characterized by blisters and erosions in skin folds, significantly impairing patients’ quality of life. HHD is caused by mutations in the ATP2C1 gene, which encodes the […]
Clinical and Dermoscopic Characteristics of Facial Hyperpigmentation Disorders in Skin of Color
Facial hyperpigmentation disorders (FHD) are common in dermatology, particularly in people with skin of color (SOC). They include melasma, post-inflammatory hyperpigmentation, and less frequent conditions such as exogenous ochronosis, lichen planus pigmentosus, Riehl’s melanosis, acanthosis […]
Spanish Clinical Management Guideline for Hidradenitis Suppurativa. Part I: Pathogenesis, Diagnosis, and Disease Staging
Hidradenitis suppurativa is a chronic inflammatory disease that typically presents with nodules, abscesses, tunnels, and scars in areas rich in pilosebaceous units, such as the axillae and the inguinal and anogenital regions. It is a […]
Management of the Impact of Psoriasis on Sexuality: Consensus Recommendations From the Psoriasis Working Group of the Spanish Academy of Dermatology and Venereology
Sexuality is a key component of quality of life; therefore, sexual dysfunction can affect both physical and emotional well-being. However, despite its high prevalence, the impact of psoriasis on patients’ sexual health is often overlooked […]
Post-Finasteride Syndrome: Survey of Dermatologists From the Spanish Hair and Nail Disorders Group
Background and objective Post-finasteride syndrome (PFS) refers to a set of persistent symptoms reported by patients after discontinuation of 5-alpha-reductase inhibitors (5-ARIs). This study aimed to explore the perception of PFS among dermatologists belonging to […]
Clinical, Histopathologic, and Surgical Aspects of Dermatofibrosarcoma Protuberans on the Head vs Other Locations: Retrospective Single-center Case Series of 235 Tumors
Background Dermatofibrosarcoma protuberans (DFSP) is a rare tumor that affects the head in 10–15% of cases. Head DFSP is often associated with more complex surgery and a higher rate of local recurrence. Objective To compare […]
Patient- and Clinician-reported Outcomes, Safety and Efficacy Profile of Tirbanibulin 1% for Actinic Keratosis Under Conditions Close to Routine Clinical Practice in Spain and Italy (TIRBASKIN Study)
Objective To assess patient- and clinician-reported outcomes, efficacy, and safety of tirbanibulin 1% administered to patients with actinic keratoses (AKs) in Spain and Italy. Methods TIRBASKIN is a multicenter, single-cohort, phase IV, low-interventional clinical study […]
Health Care Resource Utilization in Patients With Atopic Dermatitis According to Treatment Response: Evidence From the BIOBADATOP Registry
Introduction Atopic dermatitis (AD) represents a significant burden for both patients and the health care system. The objective of this study was to describe resource utilization in patients with AD according to the level of […]
